Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis
Blood Cancer J
.
2024 Jul 16;14(1):114.
doi: 10.1038/s41408-024-01101-y.
Authors
Jessica M Hislop
1
,
Molly Went
2
,
Charlie Mills
2
,
Amit Sud
3
4
5
6
,
Philip J Law
2
,
Richard S Houlston
2
Affiliations
1
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[email protected]
.
2
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
3
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
4
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
5
Harvard Medical School, Boston, MA, USA.
6
Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
PMID:
39013866
PMCID:
PMC11252326
DOI:
10.1038/s41408-024-01101-y
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Clonal Hematopoiesis* / genetics
Genetic Predisposition to Disease
Humans
Mendelian Randomization Analysis*
Risk Factors
Grants and funding
WT_/Wellcome Trust/United Kingdom
C1298/A8362/Cancer Research UK (CRUK)